These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34602938)

  • 21. Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer.
    Van Bockstal MR; Noel F; Guiot Y; Duhoux FP; Mazzeo F; Van Marcke C; Fellah L; Ledoux B; Berlière M; Galant C
    Ann Diagn Pathol; 2020 Dec; 49():151634. PubMed ID: 32987254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutrophil-lymphocyte ratio predicts response to chemotherapy in triple-negative breast cancer.
    Chae S; Kang KM; Kim HJ; Kang E; Park SY; Kim JH; Kim SH; Kim SW; Kim EK
    Curr Oncol; 2018 Apr; 25(2):e113-e119. PubMed ID: 29719435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Different Phenotypes of Locally Advanced Breast Cancer During Neoadjuvant Systemic Treatment.
    Muñoz-Montaño W; Cabrera-Galeana P; Alvarado-Miranda A; Villarreal-Garza C; Mohar A; Olvera A; Bargallo-Rocha E; Lara-Medina F; Arrieta O
    Clin Breast Cancer; 2020 Aug; 20(4):307-316.e1. PubMed ID: 32305297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of stromal and intratumoral tumor lymphocyte infiltration for pathologic complete response in patients with locally advanced breast cancer.
    Eryilmaz MK; Mutlu H; Ünal B; Salim DK; Musri FY; Coşkun HŞ
    J Cancer Res Ther; 2018; 14(3):619-624. PubMed ID: 29893329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers.
    Tian T; Ruan M; Yang W; Shui R
    Oncotarget; 2016 Jul; 7(28):44395-44405. PubMed ID: 27323808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of clinicopathologic and sonographic features with stromal tumor-infiltrating lymphocytes in triple-negative breast cancer.
    Hu L; Gu Y; Xu W; Wang C
    BMC Cancer; 2024 Aug; 24(1):997. PubMed ID: 39135184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective Trial.
    Abuhadra N; Sun R; Yam C; Rauch GM; Ding Q; Lim B; Thompson AM; Mittendorf EA; Adrada BE; Damodaran S; Virani K; White J; Ravenberg E; Sun J; Choi J; Candelaria R; Arun B; Ueno NT; Santiago L; Saleem S; Abouharb S; Murthy RK; Ibrahim N; Sahin A; Valero V; Symmans WF; Litton JK; Tripathy D; Moulder S; Huo L
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy.
    Bai YG; Gao GX; Zhang H; Zhang S; Liu YH; Duan XN; Xu L
    Chin Med J (Engl); 2020 Mar; 133(5):552-560. PubMed ID: 32044815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer.
    de Boo LW; Jóźwiak K; Ter Hoeve ND; van Diest PJ; Opdam M; Wang Y; Schmidt MK; de Jong V; Kleiterp S; Cornelissen S; Baars D; Koornstra RHT; Kerver ED; van Dalen T; Bins AD; Beeker A; van den Heiligenberg SM; de Jong PC; Bakker SD; Rietbroek RC; Konings IR; Blankenburgh R; Bijlsma RM; Imholz ALT; Stathonikos N; Vreuls W; Sanders J; Rosenberg EH; Koop EA; Varga Z; van Deurzen CHM; Mooyaart AL; Córdoba A; Groen E; Bart J; Willems SM; Zolota V; Wesseling J; Sapino A; Chmielik E; Ryska A; Broeks A; Voogd AC; van der Wall E; Siesling S; Salgado R; Dackus GMHE; Hauptmann M; Kok M; Linn SC
    ESMO Open; 2024 Mar; 9(3):102923. PubMed ID: 38452438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of serum NLR, PLR and HALP with efficacy of neoadjuvant chemotherapy and prognosis of triple-negative breast cancer.
    Lou C; Jin F; Zhao Q; Qi H
    Am J Transl Res; 2022; 14(5):3240-3246. PubMed ID: 35702128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet-to-Lymphocyte Ratio Is Associated With Favorable Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Study on 120 Patients.
    Lusho S; Durando X; Mouret-Reynier MA; Kossai M; Lacrampe N; Molnar I; Penault-Llorca F; Radosevic-Robin N; Abrial C
    Front Oncol; 2021; 11():678315. PubMed ID: 34367964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients.
    Jia W; Wu J; Jia H; Yang Y; Zhang X; Chen K; Su F
    PLoS One; 2015; 10(11):e0143061. PubMed ID: 26580962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Value of Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio, and Lymphocyte-to-White Blood Cell Ratio in Colorectal Cancer Patients Who Received Neoadjuvant Chemotherapy.
    Jia W; Yuan L; Ni H; Xu B; Zhao P
    Technol Cancer Res Treat; 2021; 20():15330338211034291. PubMed ID: 34308689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stromal Tumor Infiltrating Lymphocytes (sTILs) Were Associated with a Higher Grade and a Lower Stage of Indonesian Triple Negative Breast Cancers.
    Widodo I; Ghozali A; Purwanto I; Ferronika P
    Asian Pac J Cancer Prev; 2022 Aug; 23(8):2749-2754. PubMed ID: 36037130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of the neutrophil to lymphocyte ratio in locally advanced breast cancer.
    Alshamsan B; Elshenawy MA; Aseafan M; Fahmy N; Badran A; Elhassan T; Alsayed A; Suleman K; Al-Tweigeri T
    Oncol Lett; 2024 Sep; 28(3):429. PubMed ID: 39049989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stromal Tumor-Infiltrating Lymphocytes Associated with Immunohistopathology and Molecular Subtypes of Breast Cancer in Vietnam.
    Duong TT; Pham DTN; Duong HNT; Ly TT; Thai TA
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2523-2530. PubMed ID: 37505787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study.
    Chen Y; Chen K; Xiao X; Nie Y; Qu S; Gong C; Su F; Song E
    BMC Cancer; 2016 May; 16():320. PubMed ID: 27198767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer.
    Al Jarroudi O; El Bairi K; Abda N; Zaimi A; Jaouani L; Chibani H; Afqir S
    Biomark Med; 2021 Oct; 15(14):1289-1298. PubMed ID: 34486882
    [No Abstract]   [Full Text] [Related]  

  • 39. Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy.
    Chen L; Zuo Y; Zhu L; Zhang Y; Li S; Ma F; Han Y; Song H; Xue Y
    Onco Targets Ther; 2017; 10():2569-2580. PubMed ID: 28553122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.
    Adams S; Gray RJ; Demaria S; Goldstein L; Perez EA; Shulman LN; Martino S; Wang M; Jones VE; Saphner TJ; Wolff AC; Wood WC; Davidson NE; Sledge GW; Sparano JA; Badve SS
    J Clin Oncol; 2014 Sep; 32(27):2959-66. PubMed ID: 25071121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.